Inbrain Raises $16.8M to Advance ‘Intelligent’ Neurostimulator for Parkinson’s
Inbrain Neuroelectronics has raised $16.8 million in Series A financing to support moving into clinical testing a new neuromodulation device that uses computer learning to treat Parkinson’s disease and epilepsy. Electrodes for this next-generation neurostimulator are also based on graphene, a single layer of tightly bound carbon atoms that allows…